HRTS (HRTS) Stock Price & Analysis
HRTS (HRTS) rose 0.94% to USD 34.42 as of June 11, 2026 at 19:12 UTC, according to Nexqual real-time market data.
HRTS last closed at USD 34.1; the session ranged USD 34.04–34.42 on volume of 1,435 shares. Market capitalization is —, with a 52-week range of USD 27.24–36.65 (NGM). Source: Nexqual, June 11, 2026 at 19:12 UTC.
Key Statistics (as of June 11, 2026 at 19:12 UTC)
| Price | USD 34.42 |
|---|---|
| Change | ▲ 0.94% (up) |
| Previous Close | USD 34.1 |
| Open | USD 34.04 |
| Day Range | USD 34.04 – 34.42 |
| 52-Week Range | USD 27.24 – 36.65 |
| Volume | 1,435 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (HRTS)
Nexqual's technical model rates HRTS "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of June 11, 2026 at 19:12 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.44 (neutral) |
| vs SMA50 | Above (USD 33.85) |
| MACD | 0.1 (positive) |
Financial Health Score (HRTS)
Nexqual rates HRTS's overall financial health "Mixed" across five dimensions, as of June 11, 2026 at 19:12 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OZEM | Roundhill GLP-1 & Weight Loss E | USD 30.79 | ▲ 2.37% |
| THNR | Amplify Weight Loss Drug & Trea | USD 24.74 | ▲ 2.94% |
| CANC | Tema Oncology ETF | USD 37.14 | ▲ 0.96% |
| RSHO | Tema U.S. Manufacturing & Resho | USD 58.41 | ▼ 0.44% |
| RWJ | Invesco S&P SmallCap 600 Revenu | USD 57.93 | ▲ 1.29% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 19:12 UTC. This page is informational and not investment advice.